Onward to the Next 20 years!
Thank you for staying connected and keeping up with all of our great advances in stem cell and regenerative medicine research at UW–Madison!
Please consider making a special 20th anniversary year gift of any amount in support of our many SCRMC programs. Your gifts support groundbreaking research and collaboration, student education, and training future generations of scientists, clinicians, teachers, entrepreneurs and policy makers in the field.
Fujifilm Cellular Dynamics Inc. (FCDI) plans to invest $21 million to create a facility in Madison for manufacturing stem cell therapies that can be used as regenerative medicine — cells that can repair or rebuild a patient’s diseased or damaged tissue.January 4, 2019
First Carbone Cancer Center patient receives experimental therapy to prevent infections during chemotherapy
Peiman Hematti, MD, a bone marrow transplant physician at the University of Wisconsin Carbone Cancer Center and director of Clinical Hematopoietic Cell Processing Laboratory, is the site principal investigator for a new clinical trial using …December 20, 2018
As an undergraduate student majoring in physics at Illinois Wesleyan University, William Murphy took exactly one biology course: Biology 101. Two decades later, he’s built a career around creating what he calls “bio-inspired” materials such as tissues for drug modeling and bone regeneration. Murphy, the Harvey D. Spangler Professor of biomedical engineering and orthopedics at the University of Wisconsin-Madison, looks to nature for insights on his designs.December 11, 2018
At just two-and-a-half years old, the University of Wisconsin–Madison Human Stem Cell Gene Editing Service is already contemplating expansion. The increased demand has tracked the growth of research projects on campus using a new gene …December 11, 2018
An article in the Wisconsin State Journal described the first combined kidney and hematopoietic stem cell transplant at UW-Madison. Members of the multidisciplinary team that made the breakthrough possible included SCRMC member Peiman Hematti, MD, professor, Hematology, Medical Oncology and Palliative Care, as well as Kristi Schneider, APRN-BC, APNP, director of transplant clinical trials, Department of Surgery, Robert Redfield III, MD, assistant professor, Department of Surgery, and Kristin Bradley, MD, associate professor, Department of Human Oncology.December 2, 2018
- More News posts